The activation of Smad2 and Smad3 results in aggressive ECM deposition in interstitial and glomerulus that cause interstitial fibrosis and glomerulosclerosis in kidney respectively [56], while the inhibition of Smad3 phosphorylation retarded renal fibrosis in UUO rats [57]. Here, SMAD3 is linked to glomerulosclerosis.